Cleared Traditional

K120306 - RAPICIDE OPA-28

K120306 is an FDA 510(k) clearance for RAPICIDE OPA-28, manufactured by Minntech Corp.. The device is a Class 2 General Hospital device with product code MED cleared through the Traditional 510(k) pathway after a 239-day FDA review.

K120306 · Minntech Corp. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2012
Decision
239d
Days
Class 2
Risk

K120306 is an FDA 510(k) clearance for the RAPICIDE OPA-28. Classified as Sterilant, Medical Devices (product code MED), Class II - Special Controls.

Submitted by Minntech Corp. (Minneapolis, US). The FDA issued a Cleared decision on September 27, 2012 after a review of 239 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.6885 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Minntech Corp. devices

FDA 510(k) Submission Details - K120306

510(k) Number K120306 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 01, 2012
Decision Date September 27, 2012
Days to Decision 239 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
110d slower than avg
Panel avg: 129d · This submission: 239d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MED Device Classification - Class 2, Special Controls

Product Code MED Sterilant, Medical Devices
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.6885
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - MED Sterilant, Medical Devices

All 42
Devices cleared under the same product code (MED) and FDA review panel - the closest regulatory comparables to K120306.
SYSTEM 1E Liquid Chemical Sterilant Processing System
K170956 · STERIS Corporation · Sep 2017
SYSTEM 1E Liquid Chemical Sterilant Processing System
K161683 · STERIS Corporation · Aug 2016
SYSTEM 1E LIQUID CHEMICAL STERILANT PROCESSING SYSTEM
K131078 · STERIS Corporation · Jul 2013
SYSTEM 1E LIQUID CHEMICAL STERILANT PROCESSING SYSTEM
K113520 · STERIS Corporation · Feb 2012
SYSTEM 1E LIQUID CHEMICAL STERILANT PROCESSING SYSTEM
K102462 · STERIS Corporation · Sep 2010
SYSTEM IE LIQUID CHEMICAL CTERILANT PROCESSING SYSTEM
K101409 · STERIS Corporation · Aug 2010